These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23682974)

  • 1. White-coat hypertension.
    Martin CA; McGrath BP
    Clin Exp Pharmacol Physiol; 2014 Jan; 41(1):22-9. PubMed ID: 23682974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
    Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
    Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.
    Satoh M; Asayama K; Kikuya M; Inoue R; Metoki H; Hosaka M; Tsubota-Utsugi M; Obara T; Ishiguro A; Murakami K; Matsuda A; Yasui D; Murakami T; Mano N; Imai Y; Ohkubo T
    Hypertension; 2016 Jan; 67(1):48-55. PubMed ID: 26527046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
    Afsar B
    J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White-coat hypertension: a clinical review.
    Celis H; Fagard RH
    Eur J Intern Med; 2004 Oct; 15(6):348-357. PubMed ID: 15522568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White-coat hypertension detected during opportunistic blood pressure screening in a dental healthcare setting.
    Andersson H; Hedström L; Bergh H
    Scand J Prim Health Care; 2021 Sep; 39(3):348-354. PubMed ID: 34348568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White Coat Hypertension: to Treat or Not to Treat?
    Cuspidi C; Sala C; Grassi G; Mancia G
    Curr Hypertens Rep; 2016 Nov; 18(11):80. PubMed ID: 27787835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory and home blood pressure monitoring in children and adolescents: diagnosis of hypertension and assessment of target-organ damage.
    Karpettas N; Nasothimiou E; Kollias A; Vazeou A; Stergiou GS
    Hypertens Res; 2013 Apr; 36(4):285-92. PubMed ID: 23344131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is white-coat hypertension a harbinger of increased risk?
    Kollias A; Ntineri A; Stergiou GS
    Hypertens Res; 2014 Sep; 37(9):791-5. PubMed ID: 24599009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease.
    Boggia J; Silvariño R; Luzardo L; Noboa O
    Hypertens Res; 2014 Oct; 37(10):882-9. PubMed ID: 24739541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
    Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
    ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database.
    Tocci G; Presta V; Figliuzzi I; Attalla El Halabieh N; Battistoni A; Coluccia R; D'Agostino M; Ferrucci A; Volpe M
    J Clin Hypertens (Greenwich); 2018 Feb; 20(2):297-305. PubMed ID: 29370477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure on arising, morning blood pressure surge and blood pressure variability in white coat hypertensives and in matched normotensives and sustained hypertensives.
    Polónia J; Carvalho N; Barbosa L; Silva JA
    Rev Port Cardiol; 2006; 25(7-8):693-704. PubMed ID: 17069435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.